---
title: "Biomarkers and Pharmacodynamics Analysis"
canonical: "https://www.pharmalegacy.com/services/in-vitro-platform/biomarkers-and-pharmacodynamics-analysis/"
lastmod: "2024-07-29T12:22:51+00:00"
generator: "llm-mirrors/1.0.19"
---

Biomarkers and Pharmacodynamics Analysis
Biomarkers and PD analyses precision-crafted for your studies

Developing successful therapeutics requires a deep understanding of their drug journey within the body. At PharmaLegacy, our comprehensive suite of biomarkers and pharmacodynamics (PD) analysis empowers you to decipher the intricate relationship between drug exposure, biological effects, and therapeutic response, accelerating drug development and optimizing clinical trials.

Get In Touch Now

✕

Let PharmaLegacy provide the answers you need.

MODELS / SERVICES

Western Blot – Classic Method ▼

Western Blot by Protein Simple Jess (Fully Automatic) ▼

As low as 1 ug total protein, within 3 hours for 25 samples, with high repeatability
Capillary isoelectric focusing electrophoresis (iCIEF) based protein quantification
Quantify 3-4 proteins in one assay
Total protein normalization, no internal reference needed

qPCR ▼

Digital PCR (dPCR) Applications and Advantages ▼

Digital LightCycler® Digital PCR system:

The spectrum of fluorescence absorption covers the complete visible spectrum
Excitation light: One LED light source per channel
Excitation and emission filters for all 6 channels

MSD/Luminex/ELISA ▼

Multiplex cytokines measurement by MSD, Luminex, CBA or ELISA at a dynamic range of 6 logs at most.
Multiple sample source: cell lysate, cell supernatant, serum, plasma, different tissues.

Cytometric Bead Array ▼

Cytometric bead array (CBA) is a flow cytometry application that allows users to quantify multiple proteins simultaneously. Compared to other quantifier assays, such as enzyme-linked immunosorbent assay (ELISA) and Western blot, CBA significantly reduces sample requirements and time to results

Immune Profiling of Whole Blood and Organs from Non-human Primate Models ▼

Memory T Cell Subsets after Immunization ▼

Cytokine Expression in T cell Subsets - IL2 and IFN-gamma ▼

Committed to quality:

FDA Part 11 compliant
Animal studies strictly follow AAALAC and ILAC guidelines
Electronically managed, traceable research data
Rigorous adherence to international GLP and QA best practices
Clients have real-time remote monitoring of studies

Want your scientific discoveries to become treatments? PharmaLegacy’s the right partner for you.

✕

Let PharmaLegacy provide the answers you need.

Providing Better Data For Critical Oncology Pipeline Decisions
To advance a compound from discovery to clinical, or to halt its development, is a huge and costly decision. For the benefit of you and your company, and for the well-being of patients in need of treatment, that decision needs to be based on correct information.
Download our Integrated In Vitro Oncology Assays brochure and see why over 300 pharmaceutical companies, including many global leaders, trust PharmaLegacy for the unbiased, accurate information they need to make critical oncology pipeline decisions.

We’re ready when you are.             Tell us your pharmacology challenges.

+86-21-6176-5100*8051
+1-617-803-9415

info@pharmalegacy.com